These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 17312000)
1. Optimizing fusion transcript monitoring in CML. Hertzberg M; McDonald D Blood; 2007 Mar; 109(5):2263; author reply 2263-4. PubMed ID: 17312000 [No Abstract] [Full Text] [Related]
2. Investigation of bcr-abl transcription by Ph-positive chronic myeloid leukemia progenitors. Keating A Stem Cells; 1993 Oct; 11 Suppl 3():31-3. PubMed ID: 8298475 [TBL] [Abstract][Full Text] [Related]
3. A novel BCR-ABL rearrangement in a Philadelphia chromosome-positive chronic myelogenous leukaemia variant with thrombocythaemia. Rubinstein R; Purves LR Leukemia; 1998 Feb; 12(2):230-2. PubMed ID: 9519786 [TBL] [Abstract][Full Text] [Related]
4. Detection of BCR/ABL fusion gene in CML: a preliminary report. Rerkamnuaychoke B; Kangwanpong D; Jootar S; Puranakanitstha C Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():197-200. PubMed ID: 8629106 [TBL] [Abstract][Full Text] [Related]
5. BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis. Schultheis B; Wang L; Clark RE; Melo JV Leukemia; 2003 Oct; 17(10):2054-5. PubMed ID: 14513059 [No Abstract] [Full Text] [Related]
6. Second case of CML with aberrant BCR-ABL fusion transcript (e8/a2) with insertion of an inverted ABL intron 1b sequence. Sugimoto T; Ijima K; Hisatomi H; Murayama T; Mizuno I; Hato A; Imoto S; Nishimura R; Koizumi T Am J Hematol; 2004 Oct; 77(2):164-6. PubMed ID: 15389825 [TBL] [Abstract][Full Text] [Related]
7. Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction--is it truly a benign disease? How GF; Tan LT; Lim LC Leukemia; 1998 Jul; 12(7):1166-7. PubMed ID: 9665206 [No Abstract] [Full Text] [Related]
8. e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases. Mondal BC; Majumdar S; Dasgupta UB; Chaudhuri U; Chakrabarti P; Bhattacharyya S J Clin Pathol; 2006 Oct; 59(10):1102-3. PubMed ID: 17021137 [TBL] [Abstract][Full Text] [Related]
9. A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia. Branford S; Rudzki Z; Hughes TP Br J Haematol; 2000 Jun; 109(3):635-7. PubMed ID: 10886215 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders. Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513 [TBL] [Abstract][Full Text] [Related]
11. Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression. Dhingra K; Talpaz M; Kantarjian H; Ku S; Rothberg J; Gutterman JU; Kurzrock R Leukemia; 1991 Mar; 5(3):191-5. PubMed ID: 2013978 [TBL] [Abstract][Full Text] [Related]
12. Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples. Stock W; Yu D; Karrison T; Sher D; Stone RM; Larson RA; Bloomfield CD Int J Oncol; 2006 May; 28(5):1099-103. PubMed ID: 16596225 [TBL] [Abstract][Full Text] [Related]
13. Monitoring the efficiency of interferon-alpha therapy in chronic myelogenous leukemia (CML) patients by competitive polymerase chain reaction. Hochhaus A; Lin F; Reiter A; Skladny H; Hehlmann R; Goldman JM; Cross NC Leukemia; 1997 Apr; 11 Suppl 3():541-4. PubMed ID: 9209451 [TBL] [Abstract][Full Text] [Related]
14. Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia. Hur M; Song EY; Kang SH; Shin DH; Kim JY; Park SS; Cho HI Ann Hematol; 2002 Apr; 81(4):219-23. PubMed ID: 11976825 [TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172 [TBL] [Abstract][Full Text] [Related]
16. A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course. De Matteis G; Veneri D; Aprili F; Benati M; Paviati E; Guidi GC; Pizzolo G; Tecchio C Ann Hematol; 2013 Mar; 92(3):413-5. PubMed ID: 23053185 [No Abstract] [Full Text] [Related]
17. Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase. Moravcová J; Zmeková V; Klamová H; Voglová J; Faber E; Michalová K; Rabasová J; Jarosová M Leuk Res; 2004 Apr; 28(4):415-9. PubMed ID: 15109543 [TBL] [Abstract][Full Text] [Related]
18. The dual expression of minor and major bcr/abl chimeric mRNA in blast crisis of chronic myelogenous leukemia. Tanaka M; Yamazaki Y; Hattori M; Tsushita K; Utsumi M; Yoshida S Leuk Res; 1996 Jul; 20(7):575-80. PubMed ID: 8795691 [TBL] [Abstract][Full Text] [Related]
19. Chronic myeloid leukemia presenting ALL-type BCR/ABL transcript. Kunieda Y; Okabe M; Kurosawa M; Itaya T; Kakinuma M; Miyazaki T Ann Hematol; 1994 Oct; 69(4):189-93. PubMed ID: 7948305 [TBL] [Abstract][Full Text] [Related]
20. The differences and correlations of BCR-ABL transcripts between peripheral blood and bone marrow assays are associated with the molecular responses in the bone marrow for chronic myelogenous leukemia. Jiang Q; Zhao XY; Qin YZ; Liu YR; Lai YY; Jiang B; Huang XJ Am J Hematol; 2012 Dec; 87(12):1065-9. PubMed ID: 22965919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]